Betterlife Pharma Inc
(BETRF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 01/31
| 01-2022 | 10-2021 | 07-2021 | 04-2021 | 01-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 139 | 1,698 | 3,457 | 218 | 116 |
| Receivables | 260 | 63 | 82 | 104 | 389 |
| TOTAL | $913 | $2,392 | $4,600 | $1,113 | $995 |
| Non-Current Assets | |||||
| PPE Net | 15 | 18 | 23 | 26 | 28 |
| TOTAL | $15 | $18 | $23 | $26 | $28 |
| Total Assets | $927 | $2,410 | $4,622 | $1,139 | $1,023 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 190 | 199 | 204 | N/A | 374 |
| Accounts payable and accrued liabilities | 2,784 | 2,711 | 3,160 | 3,549 | 3,865 |
| Other current liabilities | 175 | 45 | 165 | 145 | 136 |
| TOTAL | $3,308 | $2,955 | $3,529 | $3,693 | $4,375 |
| Non-Current Liabilities | |||||
| Long Term Debt | 28 | 58 | 58 | 56 | N/A |
| Other Non-Current Liabilities | 690 | 0 | 3 | 435 | 99 |
| TOTAL | $718 | $59 | $61 | $491 | $99 |
| Total Liabilities | $4,026 | $3,014 | $3,590 | $4,184 | $4,474 |
| Shareholders' Equity | |||||
| Common Shares | 60,195 | 60,231 | 61,607 | 54,678 | 47,645 |
| Retained earnings | -82,382 | -78,969 | -78,978 | -74,250 | -68,104 |
| Other shareholders' equity | 19,088 | 18,134 | 18,403 | 16,527 | 17,008 |
| TOTAL | $-3,099 | $-604 | $1,032 | $-3,045 | $-3,451 |
| Total Liabilities And Equity | $927 | $2,410 | $4,622 | $1,139 | $1,022 |